Diagnostic criteria of acute rheumatic fever

Autoimmunity Reviews

Volumn 13, Issue 4-5, 2014, Pages 503-507

  Burke, Rebecca J ^a   Chang, Christopher ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Erythema marginatum; Group A Streptococcus; Jones criteria; Polyarthritis; Rheumatic fever; Sydenham's chorea

Indexed keywords

ACUTE PHASE PROTEIN; ANTIBIOTIC AGENT; BIOLOGICAL MARKER;

ANTIBIOTIC THERAPY; ANTIGEN DETECTION; ARTHRALGIA; CARDITIS; CHOREA; CHOREA MINOR; CLINICAL DECISION MAKING; CLINICAL FEATURE; DEVELOPING COUNTRY; DIAGNOSTIC ERROR; ERYTHEMA; FEVER; GROUP A STREPTOCOCCAL INFECTION; HUMAN; IMMUNOASSAY; INCIDENCE; LABORATORY DIAGNOSIS; LABORATORY TEST; LYME DISEASE; MEDICAL DOCUMENTATION; PATHOPHYSIOLOGY; POLYARTHRITIS; PR INTERVAL; REACTIVE ARTHRITIS; REVIEW; RHEUMATIC FEVER; SERUM SICKNESS; STREPTOCOCCAL PHARYNGITIS; SUBCUTANEOUS NODULE; THROAT CULTURE;

ERYTHEMA MARGINATUM; GROUP A STREPTOCOCCUS; JONES CRITERIA; POLYARTHRITIS; RHEUMATIC FEVER; SYDENHAM'S CHOREA;

ACUTE DISEASE; CHOREA; HUMANS; INCIDENCE; MYOCARDITIS; RHEUMATIC FEVER; STREPTOCOCCAL INFECTIONS;

EID: 84896314173     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.01.036     Document Type: Review

References (21)

1. Bland E.F. Rheumatic fever: the way it was. Circulation 1987, 76:1190-1195.
2. Gordis L. The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. T. Duckett Jones memorial lecture. Circulation 1985, 72:1155-1162.
3. Carapetis J.R., Steer A.C., Mulholland E.K., Weber M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 2005, 5:685-694.
4. Tibazarwa K.B., Volmink J.A., Mayosi B.M. Incidence of acute rheumatic fever in the world: a systematic review of population-based studies. Heart 2008, 94:1534-1540.
5. Miyake C.Y., Gauvreau K., Tani L.Y., Sundel R.P., Newburger J.W. Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever. Pediatrics 2007, 120:503-508.
6. Veasy L.G., Tani L.Y., Hill H.R. Persistence of acute rheumatic fever in the intermountain area of the United States. J. Pediatr. 1994, 124:9-16.
7. Veasy L.G., Wiedmeier S.E., Orsmond G.S., et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N. Engl. J. Med. 1987, 316:421-427.
8. Pfoh E., Wessels M.R., Goldmann D., Lee G.M. Burden and economic cost of group A streptococcal pharyngitis. Pediatrics 2008, 121:229-234.
9. Guidelines for the diagnosis of rheumatic fever. Jones criteria, 1992 update. Special Writing Group of the Committee on rheumatic fever, endocarditis, and Kawasaki disease of the council on cardiovascular disease in the young of the American Heart Association. JAMA 1992, 268:2069-2073.
10. Jones criteria (revised) for guidance in the diagnosis of rheumatic fever. Circulation 1965, 32:664-668.
11. Jones T.D. The diagnosis of rheumatic fever. JAMA 1944, 126:481-484.
12. Chang C. Cutting edge issues in rheumatic fever. Clin. Rev. Allergy Immunol. 2012, 42:213-237.
13. Rogo T., Schwartz R.H., Ascher D.P. Comparison of the Inverness Medical Acceava Strep A test with the Genzyme OSOM and Quidel QuickVue Strep A tests. Clin Pediatr (Phila) 2011, 50:294-296.
14. Cunningham M.W. Streptococcus and rheumatic fever. Curr. Opin. Rheumatol. 2012, 24:408-416.
15. Karatas Z., Baysal T., Alp H., Toker A. Serum Tenascin-C: a novel biomarker for diagnosis and predicting prognosis of rheumatic carditis?. J. Trop. Pediatr. 2013, 59(6):476-482.
16. Nelson D.C., Garbe J., Collin M. Cysteine proteinase SpeB from Streptococcus pyogenes - a potent modifier of immunologically important host and bacterial proteins. Biol. Chem. 2011, 392:1077-1088.
17. Kumar A., Bhatnagar A., Gupta S., Khare S. Suman. sof gene as a specific genetic marker for detection of Streptococcus pyogenes causing pharyngitis and rheumatic heart disease. Cell Mol Biol (Noisy-le-grand) 2011, 57:26-30.
18. Chiang-Ni C., Wu J.J. Effects of streptococcal pyrogenic exotoxin B on pathogenesis of Streptococcus pyogenes. J. Formos. Med. Assoc. 2008, 107:677-685.
19. Honda-Ogawa M., Ogawa T., Terao Y., et al. Cysteine proteinase from Streptococcus pyogenes enables evasion of innate immunity via degradation of complement factors. J. Biol. Chem. 2013, 288:15854-15864.
20. von Pawel-Rammingen U., Johansson B.P., Bjorck L. IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J. 2002, 21:1607-1615.
21. Hafez M., Yahia S., Eldars W., et al. Prediction of residual valvular lesions in rheumatic heart disease: role of adhesion molecules. Pediatr. Cardiol. 2013, 34:583-590.